Loading…

Pharmacophore and docking-based combined in-silico study of KDR inhibitors

The growth and metastasis of solid tumors is dependent on angiogenesis. The vascular endothelial growth factor (VEGF) and its cell surface receptor in human KDR (kinase domain containing receptor or VEGFR-2) have particular interest because of their importance in angiogenesis. The development of nov...

Full description

Saved in:
Bibliographic Details
Published in:Journal of molecular graphics & modelling 2009-08, Vol.28 (1), p.54-61
Main Authors: Pasha, F.A., Muddassar, M., Neaz, M.M., Cho, Seung Joo
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c385t-8ecc72aa19b6171f98ee653a9645a43d3eeef442fa3d64ca8a98d8d9884012323
cites cdi_FETCH-LOGICAL-c385t-8ecc72aa19b6171f98ee653a9645a43d3eeef442fa3d64ca8a98d8d9884012323
container_end_page 61
container_issue 1
container_start_page 54
container_title Journal of molecular graphics & modelling
container_volume 28
creator Pasha, F.A.
Muddassar, M.
Neaz, M.M.
Cho, Seung Joo
description The growth and metastasis of solid tumors is dependent on angiogenesis. The vascular endothelial growth factor (VEGF) and its cell surface receptor in human KDR (kinase domain containing receptor or VEGFR-2) have particular interest because of their importance in angiogenesis. The development of novel inhibitors of VEGFR-2 would be helpful to check the growth of tumors. Quantitative structure activity relationship (QSAR) analyses used to understand the structural factors affecting inhibitory potency of thiazole-substituted pyrazolone derivatives. Several pharmacophore-based models indicated the importance of steric, hydrophobic and hydrogen bond acceptor groups to inhibitory activity. The comparative molecular field analyses (CoMFA) and comparative molecular similarity indices analyses (CoMSIA) based 3D-QSAR models were derived using pharmacophore-based alignment. Both CoMFA ( q 2 = 0.70, r 2 = 0.97 and r predictive 2 = 0.61 ) and CoMSIA ( q 2 = 0.54, r 2 = 0.82 and r predictive 2 = 0.66 ) gave reasonable results. The molecular docking (receptor-guided technique) with a recently reported receptor structure (PDB = 1YWN) were performed. The docked alignment was subsequently used for 3D-QSAR (CoMFA; q 2 = 0.56, r 2 = 0.97, r predictive 2 = 0.82 , CoMSIA; q 2 = 0.58 r 2 = 0.91, r predictive 2 = 0.69 ). The overall both studies were indicated, steric, electrostatic and hydrogen bond acceptor effects contribute to the inhibitory activity. CoMFA and CoMSIA models suggested that a positive bulk with hydrophobic effect is desirable around position 4 and 5 and hydrogen bond acceptor groups around pyrazolones ring will be helpful.
doi_str_mv 10.1016/j.jmgm.2009.04.006
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67629006</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1093326309000448</els_id><sourcerecordid>67629006</sourcerecordid><originalsourceid>FETCH-LOGICAL-c385t-8ecc72aa19b6171f98ee653a9645a43d3eeef442fa3d64ca8a98d8d9884012323</originalsourceid><addsrcrecordid>eNqFkMtO6zAQQC0E4v0DLFBW7BLGjzq2xOaK90MCIVhbjj2hLk3ca6dI_D2pWunuLqsZjc6cxSHkhEJFgcrzWTXrPrqKAegKRAUgt8g-VTUvBRN8e9xB85IzyffIQc4zAOAK6l2yR7UQNUzqffLwMrWpsy4upjFhYXtf-Og-Q_9RNjajL1zsmtCPS-jLHObBxSIPS_9dxLZ4vHodz9PQhCGmfER2WjvPeLyZh-T95vrt8q58er69v_zzVDquJkOp0LmaWUt1I2lNW60Q5YRbLcXECu45IrZCsNZyL4WzymrllddKCaCMM35IztbeRYp_l5gH04XscD63PcZlNrKWTI8xfgUZjA1AqhFka9ClmHPC1ixS6Gz6NhTMKrWZmVVqs0ptQJi1_XRjXzYd-n8vm7YjcLEGcIzxFTCZ7AL2Dn1I6AbjY_if_wcAJI8s</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20705068</pqid></control><display><type>article</type><title>Pharmacophore and docking-based combined in-silico study of KDR inhibitors</title><source>ScienceDirect Journals</source><creator>Pasha, F.A. ; Muddassar, M. ; Neaz, M.M. ; Cho, Seung Joo</creator><creatorcontrib>Pasha, F.A. ; Muddassar, M. ; Neaz, M.M. ; Cho, Seung Joo</creatorcontrib><description>The growth and metastasis of solid tumors is dependent on angiogenesis. The vascular endothelial growth factor (VEGF) and its cell surface receptor in human KDR (kinase domain containing receptor or VEGFR-2) have particular interest because of their importance in angiogenesis. The development of novel inhibitors of VEGFR-2 would be helpful to check the growth of tumors. Quantitative structure activity relationship (QSAR) analyses used to understand the structural factors affecting inhibitory potency of thiazole-substituted pyrazolone derivatives. Several pharmacophore-based models indicated the importance of steric, hydrophobic and hydrogen bond acceptor groups to inhibitory activity. The comparative molecular field analyses (CoMFA) and comparative molecular similarity indices analyses (CoMSIA) based 3D-QSAR models were derived using pharmacophore-based alignment. Both CoMFA ( q 2 = 0.70, r 2 = 0.97 and r predictive 2 = 0.61 ) and CoMSIA ( q 2 = 0.54, r 2 = 0.82 and r predictive 2 = 0.66 ) gave reasonable results. The molecular docking (receptor-guided technique) with a recently reported receptor structure (PDB = 1YWN) were performed. The docked alignment was subsequently used for 3D-QSAR (CoMFA; q 2 = 0.56, r 2 = 0.97, r predictive 2 = 0.82 , CoMSIA; q 2 = 0.58 r 2 = 0.91, r predictive 2 = 0.69 ). The overall both studies were indicated, steric, electrostatic and hydrogen bond acceptor effects contribute to the inhibitory activity. CoMFA and CoMSIA models suggested that a positive bulk with hydrophobic effect is desirable around position 4 and 5 and hydrogen bond acceptor groups around pyrazolones ring will be helpful.</description><identifier>ISSN: 1093-3263</identifier><identifier>EISSN: 1873-4243</identifier><identifier>DOI: 10.1016/j.jmgm.2009.04.006</identifier><identifier>PMID: 19447057</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>3D-QSAR ; Anti-Inflammatory Agents, Non-Steroidal - chemistry ; Anti-Inflammatory Agents, Non-Steroidal - pharmacology ; CoMFA ; CoMSIA ; Docking ; Drug design ; Humans ; Models, Molecular ; Molecular Structure ; Pharmacophore ; Protein Binding - drug effects ; Protein Structure, Secondary ; Pyrazolones - chemistry ; Pyrazolones - pharmacology ; Quantitative Structure-Activity Relationship ; Vascular Endothelial Growth Factor Receptor-2 - antagonists &amp; inhibitors ; VEGFR</subject><ispartof>Journal of molecular graphics &amp; modelling, 2009-08, Vol.28 (1), p.54-61</ispartof><rights>2009 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c385t-8ecc72aa19b6171f98ee653a9645a43d3eeef442fa3d64ca8a98d8d9884012323</citedby><cites>FETCH-LOGICAL-c385t-8ecc72aa19b6171f98ee653a9645a43d3eeef442fa3d64ca8a98d8d9884012323</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19447057$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pasha, F.A.</creatorcontrib><creatorcontrib>Muddassar, M.</creatorcontrib><creatorcontrib>Neaz, M.M.</creatorcontrib><creatorcontrib>Cho, Seung Joo</creatorcontrib><title>Pharmacophore and docking-based combined in-silico study of KDR inhibitors</title><title>Journal of molecular graphics &amp; modelling</title><addtitle>J Mol Graph Model</addtitle><description>The growth and metastasis of solid tumors is dependent on angiogenesis. The vascular endothelial growth factor (VEGF) and its cell surface receptor in human KDR (kinase domain containing receptor or VEGFR-2) have particular interest because of their importance in angiogenesis. The development of novel inhibitors of VEGFR-2 would be helpful to check the growth of tumors. Quantitative structure activity relationship (QSAR) analyses used to understand the structural factors affecting inhibitory potency of thiazole-substituted pyrazolone derivatives. Several pharmacophore-based models indicated the importance of steric, hydrophobic and hydrogen bond acceptor groups to inhibitory activity. The comparative molecular field analyses (CoMFA) and comparative molecular similarity indices analyses (CoMSIA) based 3D-QSAR models were derived using pharmacophore-based alignment. Both CoMFA ( q 2 = 0.70, r 2 = 0.97 and r predictive 2 = 0.61 ) and CoMSIA ( q 2 = 0.54, r 2 = 0.82 and r predictive 2 = 0.66 ) gave reasonable results. The molecular docking (receptor-guided technique) with a recently reported receptor structure (PDB = 1YWN) were performed. The docked alignment was subsequently used for 3D-QSAR (CoMFA; q 2 = 0.56, r 2 = 0.97, r predictive 2 = 0.82 , CoMSIA; q 2 = 0.58 r 2 = 0.91, r predictive 2 = 0.69 ). The overall both studies were indicated, steric, electrostatic and hydrogen bond acceptor effects contribute to the inhibitory activity. CoMFA and CoMSIA models suggested that a positive bulk with hydrophobic effect is desirable around position 4 and 5 and hydrogen bond acceptor groups around pyrazolones ring will be helpful.</description><subject>3D-QSAR</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - chemistry</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - pharmacology</subject><subject>CoMFA</subject><subject>CoMSIA</subject><subject>Docking</subject><subject>Drug design</subject><subject>Humans</subject><subject>Models, Molecular</subject><subject>Molecular Structure</subject><subject>Pharmacophore</subject><subject>Protein Binding - drug effects</subject><subject>Protein Structure, Secondary</subject><subject>Pyrazolones - chemistry</subject><subject>Pyrazolones - pharmacology</subject><subject>Quantitative Structure-Activity Relationship</subject><subject>Vascular Endothelial Growth Factor Receptor-2 - antagonists &amp; inhibitors</subject><subject>VEGFR</subject><issn>1093-3263</issn><issn>1873-4243</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNqFkMtO6zAQQC0E4v0DLFBW7BLGjzq2xOaK90MCIVhbjj2hLk3ca6dI_D2pWunuLqsZjc6cxSHkhEJFgcrzWTXrPrqKAegKRAUgt8g-VTUvBRN8e9xB85IzyffIQc4zAOAK6l2yR7UQNUzqffLwMrWpsy4upjFhYXtf-Og-Q_9RNjajL1zsmtCPS-jLHObBxSIPS_9dxLZ4vHodz9PQhCGmfER2WjvPeLyZh-T95vrt8q58er69v_zzVDquJkOp0LmaWUt1I2lNW60Q5YRbLcXECu45IrZCsNZyL4WzymrllddKCaCMM35IztbeRYp_l5gH04XscD63PcZlNrKWTI8xfgUZjA1AqhFka9ClmHPC1ixS6Gz6NhTMKrWZmVVqs0ptQJi1_XRjXzYd-n8vm7YjcLEGcIzxFTCZ7AL2Dn1I6AbjY_if_wcAJI8s</recordid><startdate>20090801</startdate><enddate>20090801</enddate><creator>Pasha, F.A.</creator><creator>Muddassar, M.</creator><creator>Neaz, M.M.</creator><creator>Cho, Seung Joo</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20090801</creationdate><title>Pharmacophore and docking-based combined in-silico study of KDR inhibitors</title><author>Pasha, F.A. ; Muddassar, M. ; Neaz, M.M. ; Cho, Seung Joo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c385t-8ecc72aa19b6171f98ee653a9645a43d3eeef442fa3d64ca8a98d8d9884012323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>3D-QSAR</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - chemistry</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - pharmacology</topic><topic>CoMFA</topic><topic>CoMSIA</topic><topic>Docking</topic><topic>Drug design</topic><topic>Humans</topic><topic>Models, Molecular</topic><topic>Molecular Structure</topic><topic>Pharmacophore</topic><topic>Protein Binding - drug effects</topic><topic>Protein Structure, Secondary</topic><topic>Pyrazolones - chemistry</topic><topic>Pyrazolones - pharmacology</topic><topic>Quantitative Structure-Activity Relationship</topic><topic>Vascular Endothelial Growth Factor Receptor-2 - antagonists &amp; inhibitors</topic><topic>VEGFR</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pasha, F.A.</creatorcontrib><creatorcontrib>Muddassar, M.</creatorcontrib><creatorcontrib>Neaz, M.M.</creatorcontrib><creatorcontrib>Cho, Seung Joo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of molecular graphics &amp; modelling</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pasha, F.A.</au><au>Muddassar, M.</au><au>Neaz, M.M.</au><au>Cho, Seung Joo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacophore and docking-based combined in-silico study of KDR inhibitors</atitle><jtitle>Journal of molecular graphics &amp; modelling</jtitle><addtitle>J Mol Graph Model</addtitle><date>2009-08-01</date><risdate>2009</risdate><volume>28</volume><issue>1</issue><spage>54</spage><epage>61</epage><pages>54-61</pages><issn>1093-3263</issn><eissn>1873-4243</eissn><abstract>The growth and metastasis of solid tumors is dependent on angiogenesis. The vascular endothelial growth factor (VEGF) and its cell surface receptor in human KDR (kinase domain containing receptor or VEGFR-2) have particular interest because of their importance in angiogenesis. The development of novel inhibitors of VEGFR-2 would be helpful to check the growth of tumors. Quantitative structure activity relationship (QSAR) analyses used to understand the structural factors affecting inhibitory potency of thiazole-substituted pyrazolone derivatives. Several pharmacophore-based models indicated the importance of steric, hydrophobic and hydrogen bond acceptor groups to inhibitory activity. The comparative molecular field analyses (CoMFA) and comparative molecular similarity indices analyses (CoMSIA) based 3D-QSAR models were derived using pharmacophore-based alignment. Both CoMFA ( q 2 = 0.70, r 2 = 0.97 and r predictive 2 = 0.61 ) and CoMSIA ( q 2 = 0.54, r 2 = 0.82 and r predictive 2 = 0.66 ) gave reasonable results. The molecular docking (receptor-guided technique) with a recently reported receptor structure (PDB = 1YWN) were performed. The docked alignment was subsequently used for 3D-QSAR (CoMFA; q 2 = 0.56, r 2 = 0.97, r predictive 2 = 0.82 , CoMSIA; q 2 = 0.58 r 2 = 0.91, r predictive 2 = 0.69 ). The overall both studies were indicated, steric, electrostatic and hydrogen bond acceptor effects contribute to the inhibitory activity. CoMFA and CoMSIA models suggested that a positive bulk with hydrophobic effect is desirable around position 4 and 5 and hydrogen bond acceptor groups around pyrazolones ring will be helpful.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>19447057</pmid><doi>10.1016/j.jmgm.2009.04.006</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1093-3263
ispartof Journal of molecular graphics & modelling, 2009-08, Vol.28 (1), p.54-61
issn 1093-3263
1873-4243
language eng
recordid cdi_proquest_miscellaneous_67629006
source ScienceDirect Journals
subjects 3D-QSAR
Anti-Inflammatory Agents, Non-Steroidal - chemistry
Anti-Inflammatory Agents, Non-Steroidal - pharmacology
CoMFA
CoMSIA
Docking
Drug design
Humans
Models, Molecular
Molecular Structure
Pharmacophore
Protein Binding - drug effects
Protein Structure, Secondary
Pyrazolones - chemistry
Pyrazolones - pharmacology
Quantitative Structure-Activity Relationship
Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors
VEGFR
title Pharmacophore and docking-based combined in-silico study of KDR inhibitors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T06%3A42%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacophore%20and%20docking-based%20combined%20in-silico%20study%20of%20KDR%20inhibitors&rft.jtitle=Journal%20of%20molecular%20graphics%20&%20modelling&rft.au=Pasha,%20F.A.&rft.date=2009-08-01&rft.volume=28&rft.issue=1&rft.spage=54&rft.epage=61&rft.pages=54-61&rft.issn=1093-3263&rft.eissn=1873-4243&rft_id=info:doi/10.1016/j.jmgm.2009.04.006&rft_dat=%3Cproquest_cross%3E67629006%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c385t-8ecc72aa19b6171f98ee653a9645a43d3eeef442fa3d64ca8a98d8d9884012323%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=20705068&rft_id=info:pmid/19447057&rfr_iscdi=true